Waters Corporation $WAT Shares Sold by Toth Financial Advisory Corp

Toth Financial Advisory Corp lessened its position in Waters Corporation (NYSE:WAT) by 72.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 582 shares of the medical instruments supplier’s stock after selling 1,499 shares during the period. Toth Financial Advisory Corp’s holdings in Waters were worth $218,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. Pilgrim Global Advisors LLC acquired a new position in Waters in the second quarter valued at $466,131,171,000. BlackRock Inc. purchased a new position in Waters during the second quarter worth about $3,182,191,000. Jupiter Topco LLC acquired a new stake in Waters in the 2nd quarter worth about $623,921,000. Norges Bank acquired a new stake in Waters in the 4th quarter worth about $265,751,000. Finally, Veritas Asset Management LLP boosted its stake in Waters by 112.3% in the 4th quarter. Veritas Asset Management LLP now owns 1,241,206 shares of the medical instruments supplier’s stock worth $471,447,000 after buying an additional 656,436 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Insider Activity at Waters

In other news, Director Christopher A. Kuebler sold 3,626 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares in the company, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.31% of the company’s stock.

Waters Trading Down 1.6%

NYSE WAT opened at $414.55 on Friday. Waters Corporation has a one year low of $282.77 and a one year high of $426.22. The company’s 50 day moving average price is $387.53 and its 200 day moving average price is $348.45. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. The firm has a market capitalization of $40.73 billion, a price-to-earnings ratio of 103.38, a PEG ratio of 2.41 and a beta of 1.19.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, topping analysts’ consensus estimates of $3.01 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The firm’s quarterly revenue was up 113.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, sell-side analysts predict that Waters Corporation will post 14.56 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on WAT. JPMorgan Chase & Co. upped their price objective on shares of Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $400.00 target price on shares of Waters in a report on Wednesday, August 5th. Wolfe Research assumed coverage on shares of Waters in a research note on Tuesday, June 2nd. They set an “outperform” rating and a $425.00 price target on the stock. Morgan Stanley set a $430.00 price target on shares of Waters in a report on Wednesday, August 5th. Finally, Wall Street Zen upgraded shares of Waters from a “hold” rating to a “buy” rating in a report on Saturday. Three investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, Waters currently has a consensus rating of “Moderate Buy” and a consensus target price of $424.35.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.